Management of Ardhavabhedaka (~Migraine) with folklore and Ayurveda medicines: A single case report
Abstract
The International Classification of Headache Disorders-3 classifies Migraine as a common and disabling primary headache disorder. The Global Burden of Disease 2019 study estimates that about 1.1 billion people worldwide experience migraine, with a prevalence of around 14%. This high prevalence poses challenges for the healthcare systems. Migraine ranks second in Years Lived with Disability among all diseases and are particularly common in women of childbearing age (15–49 years), affecting 21% to 28% annually. Here, we present the case report of a 34-year-old female patient who visited the outpatient department with a throbbing left-sided headache associated with nausea, photophobia, phonophobia, ocular pain, and cutaneous allodynia while combing and washing her face since last one day. The patient also had episodes of throbbing headaches for the past 17 years. The management was done on inpatient and outpatient basis with Ayurveda internal medications including
Pathyaksha dhatryadi kashaya
along with the external application of
Sahadevi–Navaneeta lepa
(~anointment) on forehead, temple area, cheek, and lateral neck region followed by
Pathya
(~wholesome) diet and lifestyle regimen for four months. The distinctiveness of the case is the external application of
Sahadevi–Navaneeta lepa,
which is one of the Folk medicines used in Kerala by few traditional practitioners. The patient showed remarkable improvement in the severity, duration, and frequency of headaches within three…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.